Commercialization Services

Effectively progressing a product from concept through life-cycle management requires a small organization to develop and continually refine a clinical and economic product dossier.

Contact Us to Learn More

We support our clients with Real-World Evidence (RWE) Data Solutions and Commercialization strategies.  Facet helps small organizations generate evidence and build value from research and development to pre-launch to market positioning.  In tandem, Facet works with your team to maximize post-product commercial launch positioning for patients, physicians, and payers.

Whether you plan to exit early or see your product all the way to commercialization, our approach facilitates maximum market value and positions you to achieve long term success.

Begin your Facet success story today!

Facet’s commercialization services include:

Market understanding:

  • Unmet medical need, including disease prognosis, disease progression, adverse events,
  • Natural history of disease
  • Current medical practice and treatment algorithms/guidelines
  • Market sizing – incidence, prevalence, duration of treatment, new treatment pathways, product adaption, payer adaption
  • Understanding patient populations – treatments received by patient type, outcomes by patient type or treatment
  • Competitive landscape analysis

Informing development:

  • Use of real-world data to inform trial design (i.e., patient inclusion/exclusion criteria, feasibility assessment, and clinical endpoints)
  • Clinical trial results inform product modeling, reimbursement strategy, and market position

Demonstrating asset value:

  • Informing post-product launch positioning for patients, physicians, and (efficacy, HRQoL, costs)
  • Competitor analysis – likely effectiveness targets required to displace established competitors, potential safety benefits, potential cost-savings, and patient benefits
  • Validation of:
    • Efficacy – proving that real-world effectiveness matches efficacy shown in randomized clinical trials (RCTs)
    • Safety – generating long-term safety data to provide reassurance to patients, prescribing physicians, health authorities, and payer coverage policy experts

Health Economics and Outcomes Research (HEOR):

  • Systematic literature reviews
  • Health economic gap analysis and mitigation of clinical and economic evidence gaps
  • Model structure identification (e.g., cost-effectiveness modeling, budget impact) and specification
  • Iterative validation of product patient, physician, and payer value at each stage of product development
  • Quality-of-life end points

Post-launch:

  • Validation of regulatory, clinical, medical, and economic assumptions to increase market and patient access, including:
    • Market impact – impact of launched brand on standard of care, treatment algorithm, etc.
    • Remaining unmet needs – prognosis, disease progression, adverse events
    • Market sizing – market share, eligible market share based on label, off-label use

Lifecycle Management:

  • Line extension or new indications- real-world use analysis, pragmatic trials to support regulatory applications.

Summary of an Integrated Value Strategy Platform

Health Economics:

  • Early-stage economic modeling
  • Cost-effectiveness modeling
  • Burden of illness modeling
  • Epidemiology modeling
  • Cost-sharing modeling

U.S. / Global Value Dossier Development

Market understanding strategy development of dossier:

  • Commercial strategy
  • Assessment of payer perceptions and acceptance
  • Payer ad boards
  • Payer communication- understanding payer evidence needs

Pricing:

  • Qualitative and quantitative pricing research
  • Pricing strategy (e.g., evidence-based pricing strategy, value-based pricing strategy)
  • Value proposition development: Value to whom?
  • Messaging the true value of the product

Through to implementation of full service communications

Development

  • Stakeholder identification and educational needs mapping
  • Key external HCP expert identification and mapping
  • Competitor landscape mapping
  • Lexicon analysis
  • Scientific platform development
  • Communication strategy and plan development
  • Advisory boards
  • Clinical study recruitment / retention support
  • Investigator meetings
  • Publication planning and delivery

Pre-Launch

  • Activation of communication plan for all audiences
  • Internal company education and awareness (e-learning, news updates, etc)
  • HCP medical education materials
  • Scientific symposia
  • Advisory boards
  • Clinical study recruitment / retention support
  • Investigator meetings
  • Publication activities

Launch

  • Continue activation of communication plan as per
    pre-launch
  • Affiliate medical meetings and best-practice sharing
  • Affiliate launch kit
  • HCP promotional materials
  • HCP medical education materials
  • Scientific symposia
  • Standalone meetings
  • Advisory boards
  • Clinical study recruitment / retention support
  • Investigator meetings
  • Publication activities
  • Phase IV clinical strategy development

Growth

  • Competitor landscape mapping
  • Continue communication activities as per pre-launch and launch for original indication and evidence grows
  • Product-specific RWE study activities
  • Revisit all ‘Development stage’ activities for new indications and / or formulations

Maturity

  • Continue communication activities for newer indications
  • Identify need for clinically sound post hoc analyses

Contact Facet today to establish and refine your product’s clinical and economic dossier to facilitate maximum market value and long-term market success!

Top Regulatory Service Provider